XCUR

Exicure, Inc. Common Stock

0.95

USD

+0.06

+6.71%

Nov 06, 15:59 UTC -5

Closed

Pre-Market

0.90

-0.05

-5.14%

Exicure, Inc. Common Stock (XCUR) Earnings

XCUR Earnings Reports

Positive Surprise Ratio

XCUR beat 9 of 17 last estimates.

53%

Next Report

Today

Date of Next Report

Nov 05, 2026

Estimate for Q3 26 (Revenue/ EPS)

Implied change from Q2 26 (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

Exicure, Inc. Common Stock earnings per share and revenue

On Aug 06, 2026, XCUR reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q3 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Aligos Therapeutics, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$2.21

Actual

-$2.09

Surprise

+5.58%

CervoMed Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.49

Actual

-$0.39

Surprise

+21.97%

Creative Medical Technology Holdings, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.24

Actual

-$0.40

Surprise

-63.40%

Medicus Pharma Ltd. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$6.75

Actual

-$11.64

Surprise

-72.25%

Moderna, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$1.27

Actual

$0.38

Surprise

+129.79%

Bio-Techne Corp.

Report Date

Nov 06, 2026 For Q1 27

Estimate

$0.44

Actual

$0.44

Surprise

-1.96%

Immunocore Holdings plc - ADR

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.13

Actual

-$0.28

Surprise

-104.08%

Entera Bio Ltd. Ordinary Shares

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.06

Actual

-$0.11

Surprise

-58.50%

Vogenx Inc Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.16

Actual

-$0.47

Surprise

-187.99%

Agenus Inc.

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.27

Actual

$0.02

Surprise

+107.26%

FAQ

What were Exicure, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Exicure, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Exicure, Inc. Common Stock's Q2 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Exicure, Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 05, 2026.

What are the forecasts for Exicure, Inc. Common Stock's next earnings report?

Based on -- analysts, Exicure, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.